title: Financial burden of health services for people with HIV/AIDS in India.
abstract: In resource-limited settings, illness can impose a major financial burden on patients and their families. With the advent and increasing accessibility of antiretroviral therapy, HIV/AIDS has now become a fundamentally chronic treatable disease with far reaching economic and social consequences, and hence it is crucial to also examine the long-term financial impact of HIV healthcare. Beyond the direct costs of medications, monitoring, and medical care, additional costs include the long-term lost earnings of HIV-infected individuals as well as of their household members who also provide care. A clearer understanding of the financial burden of healthcare for HIV-infected Indians can allow policy makers and planners to better allocate limited resources. This article reviews the financial consequences of HIV care and treatment on individuals and their households by examining current treatment options, HIV monitoring, the clinical course of HIV disease, and the roles of the private and public sector in providing HIV care in India. Future studies should more thoroughly examine the financial impact of HIV-related costs incurred by households over time and examine household responses to these costs.
authors.affiliation: YRG Centre for AIDS Research & Education, Voluntary Health Services, Chennai, Tamil Nadu, India. kumarasamy@yrgcare.org
authors.forename: N
authors.initials: N
authors.lastname: Kumarasamy
authors.forename: K K
authors.initials: KK
authors.lastname: Venkatesh
authors.forename: K H
authors.initials: KH
authors.lastname: Mayer
authors.forename: Kenneth
authors.initials: K
authors.lastname: Freedberg
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000191:economics / Q000628:therapy; D019380:Anti-HIV Agents / Q000191:economics; D017281:Cost of Illness; D015658:HIV Infections / Q000191:economics* / Q000628:therapy*; D017048:Health Care Costs; D006297:Health Services Accessibility; D006801:Humans; D007194:India; D017149:Private Sector; D017150:Public Sector
chemical_list: D019380:Anti-HIV Agents